These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12402596)

  • 1. A rapid assay for icodextrin determination in plasma and dialysate.
    Wang R; Moberly JB; Martis L; Shockley TR; Mongoven JW; Patel H; Kunzler J; Hughes G; Gass J
    Adv Perit Dial; 2002; 18():91-5. PubMed ID: 12402596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
    García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
    Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis.
    Stachowska-Pietka J; Waniewski J; Olszowska A; Garcia-Lopez E; Wankowicz Z; Lindholm B
    Sci Rep; 2023 Apr; 13(1):6526. PubMed ID: 37085652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.
    Akonur A; Holmes CJ; Leypoldt JK
    Perit Dial Int; 2015; 35(3):288-96. PubMed ID: 24584610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid.
    Anderstam B; García-López E; Heimbürger O; Lindholm B
    Perit Dial Int; 2003; 23(2):146-50. PubMed ID: 12713081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of icodextrin interference with serum amylase assays.
    Wang R; Leesch V; Turner P; Moberly JB; Martis L
    Adv Perit Dial; 2002; 18():96-9. PubMed ID: 12402597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of cefepime in icodextrin peritoneal dialysis solution.
    Elwell RJ; Volino LR; Frye RF
    Ann Pharmacother; 2004 Dec; 38(12):2041-4. PubMed ID: 15494381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer.
    Wens R; Taminne M; Devriendt J; Collart F; Broeders N; Mestrez F; Germanos H; Dratwa M
    Perit Dial Int; 1998; 18(6):603-9. PubMed ID: 9932659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
    Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
    Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newly Developed Neutralized pH Icodextrin Dialysis Fluid: Nonclinical Evaluation.
    Yamaguchi N; Miyamoto K; Murata T; Ishikawa E; Horiuchi T
    Artif Organs; 2016 Aug; 40(8):E158-66. PubMed ID: 27530675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
    de Waart DR; Zweers MM; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
    Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
    Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of vancomycin in icodextrin peritoneal dialysis solution.
    Nornoo AO; Elwell RJ
    Ann Pharmacother; 2006 Nov; 40(11):1950-4. PubMed ID: 17062839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of tobramycin and ceftazidime in icodextrin peritoneal dialysis solution.
    Pallotta KE; Elwell RJ; Nornoo AO; Manley HJ
    Perit Dial Int; 2009; 29(1):52-7. PubMed ID: 19164253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Polydispersity Glucose Polymers as Osmotic Agents for Peritoneal Dialysis.
    Leypoldt JK; Hoff CM; Akonur A; Holmes CJ
    Perit Dial Int; 2015; 35(4):428-35. PubMed ID: 24584616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions.
    Barre DE; Chen C; Cooker L; Moberly JB
    Adv Perit Dial; 1999; 15():12-6. PubMed ID: 10682064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.